AMR101
Showing 1 - 25 of 41
Colorectal Adenoma, Colorectal Cancer, Endoscopic Surgery Trial in Boston (AMR101)
Completed
- Colorectal Adenoma
- +4 more
- AMR101
-
Boston, MassachusettsMassachusetts General Hospital
Nov 18, 2022
Lipid Disorder, Triglycerides High, Dyslipidemias Trial in Philadelphia (Icosapent Ethyl 1000 MG [Vascepa])
Completed
- Lipid Disorder
- +2 more
- Icosapent Ethyl 1000 MG [Vascepa]
-
Philadelphia, PennsylvaniaPerelman School of Medicine at the University of Pennsylvania
Oct 15, 2021
Colon Cancer Trial in Boston (AMR101 (VASCEPA, icosapent ethyl))
Withdrawn
- Colon Cancer
- AMR101 (VASCEPA, icosapent ethyl)
-
Boston, MassachusettsMassachusetts General Hospital
Nov 10, 2021
Cardiovascular Diseases Trial in Worldwide (AMR101, Placebo, Statin therapy)
Completed
- Cardiovascular Diseases
- AMR101
- +2 more
-
Birmingham, Alabama
- +409 more
Mar 21, 2022
Pneumococcal Vaccines Trial in United States (31 valent pneumococcal conjugate vaccine, 20 valent pneumococcal conjugate
Recruiting
- Pneumococcal Vaccines
- 31 valent pneumococcal conjugate vaccine
- 20 valent pneumococcal conjugate vaccine
-
Mobile, Alabama
- +24 more
Nov 20, 2023
Aortic Root Dilatation in Tetralogy of Fallot Patients
Not yet recruiting
- Congenital Heart Disease
- +2 more
- CT
- (no location specified)
Oct 7, 2023
Antibody-mediated Rejection, Lung Transplant Rejection Trial (Extracorporeal Photopheresis)
Not yet recruiting
- Antibody-mediated Rejection
- Lung Transplant Rejection
- Extracorporeal Photopheresis
- (no location specified)
Oct 30, 2023
Hip Fractures Trial in Sohag (Bupivacaine Hydrochloride)
Not yet recruiting
- Hip Fractures
- Bupivacaine Hydrochloride
-
Sohag, EgyptSohag University Hospital
Feb 20, 2023
COVID19 Trial in Rosario (Icosapent ethyl (IPE), Placebo)
Completed
- COVID19
- Icosapent ethyl (IPE)
- Placebo
-
Rosario, Santa Fe, ArgentinaInstituto de Investigaciones Clínicas - Rosario
Sep 10, 2021
Ultrasonography and Electrophysiology in GBS
Not yet recruiting
- Guillain-Barre Syndrome
- nerve ultrasonography
- (no location specified)
Jun 5, 2022
Severe Stroke, Electroacupuncture Trial in Guangzhou (Electroacupuncture)
Recruiting
- Severe Stroke
- Electroacupuncture
- Electroacupuncture
-
Guangzhou, Guangdong, ChinaThe Second Affiliated Hospital of Guangzhou University of Chines
Oct 25, 2022
Renal Transplant Recipient Trial in Atlanta (Belatacept, Abatacept)
Recruiting
- Renal Transplant Recipient
-
Atlanta, GeorgiaEmory University Hospital (EUH)
Sep 23, 2021
Tourette Syndrome in Children, Tourette Syndrome in Adolescence Trial in Worldwide (Ecopipam)
Recruiting
- Tourette Syndrome in Children
- Tourette Syndrome in Adolescence
-
Dothan, Alabama
- +78 more
Nov 23, 2021
Video-assisted Thoracic Surgery Trial (programmed intermittent epidural bolus, continuous epidural infusion, ropivacaine and
Not yet recruiting
- Video-assisted Thoracic Surgery
- programmed intermittent epidural bolus
- +2 more
- (no location specified)
Jul 3, 2023
Pain, Neuropathic Trial in Chicago (Ketamine, (2R,6R)-hydroxynorketamine, Saline)
Not yet recruiting
- Pain, Neuropathic
- Ketamine
- +2 more
-
Chicago, IllinoisRush University Medical Center
May 8, 2023
Covid19, SARS-Associated Coronavirus Trial in Brazil (Fluvoxamine Maleate 100 MG [Luvox], Budesonide Powder, Placebo (mild
Recruiting
- Covid19
- SARS-Associated Coronavirus
- Fluvoxamine Maleate 100 MG [Luvox]
- +4 more
-
Betim, MG, Brazil
- +11 more
Jul 3, 2022
Anesthesia, Regional Trial in Toronto (Femoral Articular Branch Block, Placebo Block)
Recruiting
- Anesthesia, Regional
- Femoral Articular Branch Block
- Placebo Block
-
Toronto, Ontario, CanadaWomen's College Hospital
Oct 18, 2021
Osteoarthritis, Knee, Chronic Pain Trial (Radiofrequency ablation)
Not yet recruiting
- Osteoarthritis, Knee
- Chronic Pain
- Radiofrequency ablation
- (no location specified)
Jul 4, 2023
Maternal Death, Maternal Infections Affecting Fetus or Newborn, Neonatal SEPSIS Trial in Worldwide (Azithromycin, Placebo)
Active, not recruiting
- Maternal Death
- +5 more
- Azithromycin
- Placebo
-
Dhaka, Bangladesh
- +7 more
Oct 12, 2022
Critical Illness Trial in Zagazig
Completed
- Critical Illness
-
Zagazig, Sharkia, EgyptEmergency, Surgical Intensive Care Units,medical, pulmonary, cor
Jun 19, 2020
Attention-Deficit/Hyperactivity Disorder Trial in United States (Extended-release Guanfacine Hydrochloride, Placebo)
Completed
- Attention-Deficit/Hyperactivity Disorder
- Extended-release Guanfacine Hydrochloride
- Placebo
-
Dothan, Alabama
- +53 more
Jun 25, 2021
Diarrhea-predominant Irritable Bowel Syndrome Trial in Krefeld, Ulm (Allogeneic microbiota reconstitution, Placebo-Allogeneic
Unknown status
- Diarrhea-predominant Irritable Bowel Syndrome
- Allogeneic microbiota reconstitution
- Placebo-Allogeneic microbiota reconstitution
-
Krefeld, Germany
- +1 more
Jan 30, 2020